Pharmacodynamic modelling of intravenous antibiotic prophylaxis in elective colorectal surgery

International Journal of Antimicrobial Agents

Volumn 41, Issue 2, 2013, Pages 167-173

  Moine, P ^a   Fish, D N ^b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Antibiotic prophylaxis; Colorectal surgery; Healthcare associated infections; Pharmacokinetic pharmacodynamic analysis; Surgical site infection

Indexed keywords

BETA LACTAM ANTIBIOTIC; CEFAZOLIN; CEFOTETAN; CEFOXITIN; CEFTRIAXONE; CEFUROXIME; CREATININE; ERTAPENEM; SULTAMICILLIN;

ADULT; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEROIDES FRAGILIS; BACTEROIDES INFECTION; CLINICAL EVALUATION; COLORECTAL SURGERY; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; ELECTIVE SURGERY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; HUMAN; INFECTION PREVENTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; SURGICAL INFECTION;

ADMINISTRATION, INTRAVENOUS; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BACTEROIDES FRAGILIS; BETA-LACTAMS; COLORECTAL SURGERY; ESCHERICHIA COLI; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; PREOPERATIVE CARE; STAPHYLOCOCCUS AUREUS; SURGICAL WOUND INFECTION;

EID: 84872299652     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2012.09.017     Document Type: Article

References (30)

1. K.B. Kirkland, J.P. Briggs, S.L. Trivette, W.E. Wilkinson, and D.J. Sexton The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs Infect Control Hosp Epidemiol 20 1999 725 730
2. D.W. Bratzler, P.M. Houck Surgical Infection Prevention Guideline Writers Workgroup Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project Am J Surg 189 2005 395 404 (Pubitemid 40488232)
3. E.P. Dellinger, P.A. Gross, T.L. Barrett, P.J. Krause, W.J. Martone, and J.E. McGowan Quality standard for antimicrobial prophylaxis in surgical procedures. Infectious Diseases Society of America Clin Infect Dis 18 1994 422 427 (Pubitemid 24086316)
4. R.L. Nelson, A.M. Glenny, and F. Song Antimicrobial prophylaxis for colorectal surgery Cochrane Database Syst Rev 2009 CD001181
5. D.W. Bratzler, and D.R. Hunt The Surgical Infection Prevention and Surgical Care Improvement Projects: national initiatives to improve outcomes for patients having surgery Clin Infect Dis 43 2006 322 330 (Pubitemid 44088320)
6. K. Lassen, M. Soop, J. Nygren, P.B. Cox, P.O. Hendry, and C. Spies Consensus review of optimal perioperative care in colorectal surgery: Enhanced Recovery After Surgery (ERAS) group recommendations Arch Surg 144 2009 961 969
7. W.A. Craig Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men Clin Infect Dis 26 1998 1 12 (Pubitemid 28068148)
8. S.A. Zelenitsky, R.E. Ariano, G.K.M. Harding, and R.E. Silverman Antibiotic pharmacodynamics in surgical prophylaxis: an association between intraoperative antibiotic concentrations and efficacy Antimicrob Agents Chemother 46 2002 3026 3030
9. B.T. McNamara, R.D. Meyer, and K.A. Pasiecznik In vitro susceptibility of cephalothin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to amikacin and selected new β-lactam agents Antimicrob Agents Chemother 21 1982 753 757 (Pubitemid 12006523)
10. H.S. Sader, R.N. Jones, A.C. Gales, P. Winokur, K.C. Kugler, and M.A. Pfaller Antimicrobial susceptibility patterns for pathogens isolated from patients in Latin American medical centers with a diagnosis of pneumonia: analysis of results from the SENTRY Antimicrobial Surveillance Program (1997). SENTRY Latin America Study Group Diagn Microbiol Infect Dis 32 1998 289 301 (Pubitemid 29062878)
11. A. Isla, I.F. Trocóniz, I. Lopez de Tejada, S. Vázquez, A. Canut, and J.M. López Population pharmacokinetics of prophylactic cefoxitin in patients undergoing colorectal surgery Eur J Clin Pharmacol 68 2012 735 745
12. C. Martin, C. Portet, D. Lambert, B. Bruquerolle, B. Sastre, and P. De Micco Pharmacokinetics and tissue penetration of single-dose cefotetan used for antimicrobial prophylaxis in patients undergoing colorectal surgery Antimicrob Agents Chemother 36 1992 1115 1118
13. A. Wildfeuer, V. Müller, M. Springsklee, and H.G. Sonntag Pharmacokinetics of ampicillin and sulbactam in patients undergoing heart surgery Antimicrob Agents Chemother 35 1991 1772 1776
14. M. Chen, A.N. Nafziger, G.L. Drusano, L. Ma, and J.S. Bertino Jr. Comparative pharmacokinetics and pharmacodynamic target attainment of ertapenem in normal-weight, obese, and extremely obese individuals Antimicrob Agents Chemother 50 2006 1222 1227
15. A.K. Majumdar, D.G. Musson, and K.L. Birk Pharmacokinetics of ertapenem in healthy young volunteers Antimicrob Agents Chemother 46 2002 3506 3511 (Pubitemid 35192918)
16. C. Martin, J. Ragni, F. Lokiec, J.C. Guillen, A. Auge, and M. Pecking Pharmacokinetics and tissue penetration of a single dose of ceftriaxone (1,000 milligrams intravenously) for antibiotic prophylaxis in thoracic surgery Antimicrob Agents Chemother 36 1992 2804 2807
17. T. Kosaka, K. Hosokawa, N. Shime, F. Taniguchi, T. Kokufu, and S. Hashimoto Effects of renal function on the pharmacokinetics and pharmacodynamics of prophylactic cefazolin in cardiothoracic surgery Eur J Microbiol Infect Dis 31 2012 193 199
18. A. Douglas, A.A. Udy, S.C. Wallis, P. Jarrett, J. Stuart, and M. Lassig-Smith Plasma and tissue concentrations of cefazolin in patients undergoing elective and semielective abdominal aortic aneurysm open repair surgery Antimicrob Agents Chemother 55 2011 5238 5242
19. J.W. Nascimento, M.J. Carmona, T.M. Strabelli, J.O. Auler Jr., and S.R. Santos Perioperative cefuroxime pharmacokinetics in cardiac surgery Clinics (Sao Paulo) 62 2007 257 260
20. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty-first informational supplement. Document M100-S21. Wayne, PA: CLSI; 2011.
21. C.R. Frei, N.P. Wiederhold, and D.S. Burgess Antimicrobial breakpoints for Gram-negative aerobic bacteria based on pharmacokinetic-pharmacodynamic models with Monte Carlo simulation J Antimicrob Chemother 61 2008 621 628 (Pubitemid 351321137)
22. J.W. Mouton, M.N. Dudley, O. Cars, H. Derendorf, and G.L. Drusano Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an update J Antimicrob Chemother 55 2005 601 607 (Pubitemid 40691835)
23. K.M. Itani, S.E. Wilson, S.S. Awad, E.H. Jensen, T.S. Finn, and M.A. Abramson Ertapenem versus cefotetan prophylaxis in elective colorectal surgery N Engl J Med 355 2006 2640 2651 (Pubitemid 44969123)
24. D.J. Sexton Carbapenems for surgical prophylaxis? N Engl J Med 355 2006 2693 2695 (Pubitemid 44969130)
25. F. Song, and A.M. Glenny Antimicrobial prophylaxis in colorectal surgery: a systematic review of randomized controlled trials Br J Surg 85 1998 1232 1241 (Pubitemid 28430426)
26. P. Moine, and K. Asehnoune Antibiotic prophylaxis in colorectal surgery N Engl J Med 356 2007 1684
27. T.J. Suffoletta, H.R. Jennings, J.J. Oh, D. Stephens, and K.L. Poe Continuous versus intermittent infusion of prophylactic cefoxitin after colorectal surgery: a pilot study Pharmacotherapy 28 2008 1133 1139
28. J.W. Mouton, and A.A. Vinks Is continuous infusion of β-lactam antibiotic worthwhile? Efficacy and pharmacokinetic considerations J Antimicrob Chemother 38 1996 5 15 (Pubitemid 126449204)
29. P.S. McKinnon, J.A. Paladino, and J.J. Schentag Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T > MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections Int J Antimicrob Agents 31 2008 345 351
30. P.C. Kohner, F.J.L. Robberts, F.R. Cockerill, and R. Patel Cephalosporin MIC distribution of extended-spectrum-β-lactamase- and pAmpC-producing Escherichia coli and Klebsiella species J Clin Microbiol 47 2009 2419 2425